Do sleep restriction, circadian misalignment, menopausal hormone decline, and inflammation reinforce HPA-axis dysregulation and lower peripheral T4-to-T3 conversion?

Based on the clinical and mechanistic evidence, the claim that sleep restriction, circadian misalignment, menopausal hormone decline, and inflammation interact to drive HPA-axis dysregulation is fully supported by science, while the claim that all four factors reduce peripheral T4-to-T3 conversion is plausible but partially inaccurate due to the opposing effects of sleep restriction.

HPA-Axis Dysregulation and Hormonal Feedback Loops

• Hormonal Decline and HPA Reactivity: During the menopause transition, the decline of ovarian hormones (estrogen and progesterone) removes crucial negative feedback control over the HPA axis. This loss of feedback increases HPA-axis reactivity, yielding elevated bedtime cortisol and a blunted cortisol awakening response (CAR).
• Sleep and Circadian Disruption: Sleep restriction and fragmentation directly elevate evening cortisol levels and blunt the CAR. Because sleep onset normally inhibits cortisol secretion, sleep loss disrupts this natural constraint. Concurrently, circadian misalignment disrupts the master pacemaker in the suprachiasmatic nucleus (SCN), which alters the phase and amplitude of cortisol release, contributing to a flattened diurnal cortisol slope.
• Inflammatory Feed-Forward Loop: Menopausal estrogen decline, sleep restriction, and circadian misalignment all independently promote a pro-inflammatory state, elevating circulating cytokines such as IL-6 and TNF-alpha. These chronically elevated cytokines stimulate HPA-axis activity, while persistent axis activation leads to glucocorticoid receptor resistance. This creates a feed-forward loop where inflammation and HPA-axis hyperactivity continuously reinforce one another.

Peripheral T4-to-T3 Thyroid Conversion

• Cytokine-Mediated Suppression: Systemic inflammation is a well-established suppressor of active thyroid hormone conversion. Pro-inflammatory cytokines (IL-6 and TNF-alpha) directly inhibit activating deiodinases (D1 and D2) while upregulating the inactivating deiodinase (D3). This shift reduces peripheral T3 and elevates reverse T3 (rT3), mimicking non-thyroidal illness syndrome (NTIS).
• Circadian and Menopausal Modulation: Deiodinase expression patterns (specifically Dio2 and Dio3) are under direct circadian control, meaning circadian misalignment alters the temporal gating of local T3 availability. Additionally, declining estradiol levels post-menopause are linked to reduced 5′-deiodinase-I activity and slower T4-to-T3 metabolism.
• Compensatory Sleep Response: In contrast to the other factors, sleep restriction does not reduce conversion. Human and rodent studies demonstrate that acute or sustained sleep deprivation actually upregulates D2 expression and activity as an adaptive, thermoregulatory, and energy-mobilizing mechanism, maintaining or even increasing local and systemic T3 levels.

Bottom line

The intersection of menopausal hormone decline, circadian misalignment, and systemic inflammation creates a powerful feed-forward cycle that drives chronic HPA-axis dysregulation and impairs peripheral T4-to-T3 conversion. However, sleep restriction is an exception to the thyroid portion of the claim; rather than reducing conversion, sleep loss triggers a compensatory upregulation of deiodinase activity to preserve active T3 levels.